Depot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patients

scientific article

Depot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/YIC.0B013E3282F2B4C5
P698PubMed publication ID18301123

P50authorDavid J. BondQ52146724
P2093author name stringLakshmi N Yatham
Rao N Malempati
P433issue2
P921main subjectbipolar disorderQ131755
patientQ181600
risperidoneQ412443
P304page(s)88-94
P577publication date2008-03-01
P1433published inInternational Clinical PsychopharmacologyQ15751307
P1476titleDepot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patients
P478volume23

Reverse relations

cites work (P2860)
Q35965634A Systemic Review and Experts' Consensus for Long-acting Injectable Antipsychotics in Bipolar Disorder
Q34661499Almost all antipsychotics result in weight gain: a meta-analysis
Q34122946Emerging treatments in the management of bipolar disorder - focus on risperidone long acting injection.
Q37426143Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology
Q34267385Long-acting injectable antipsychotics for the maintenance treatment of bipolar disorder
Q33886093Long-acting risperidone: a review of its role in the treatment of bipolar disorder
Q42252223Patient perspectives on use of long-acting antipsychotics in bipolar disorder: focus on risperidone injection
Q37803220Risperidone long-acting injectable (Risperdal Consta®) for maintenance treatment in patients with bipolar disorder
Q37756971Risperidone long-acting injection as monotherapy and adjunctive therapy in the maintenance treatment of bipolar I disorder
Q37062563Risperidone long-acting injection: a review of its long term safety and efficacy
Q42359424Severe weight gain with long-acting injectable risperidone: a case report
Q34649187The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder
Q38003199The clinical management of bipolar disorder complexity using a stratified model
Q37225867Use of risperidone long-acting injectable in a rural border community clinic in southern california
Q38116564What is the evidence for the use of second-generation antipsychotic long-acting injectables as maintenance treatment in bipolar disorder?

Search more.